OTC - ACTIVE INGREDIENT SECTION
zinc oxide
zinc oxide
water, cyclopentasiloxane, ethylhexyl methoxycinnamate, glycerin, ethylhexyl salicylate, peg-10 dimethicone, dipropylene glycol, cyclomethicone, betaine, disteardimonium hectorite, hexyl laurate, magnesium sulfate, talc, aluminum hydroxide, aluminum stearate, methylparaben palmitic acid, acrylates/dimethicone copolymer, fragrance, imidazolidinyl urea, chromium, oxide greens, dimethicone/vinyl dimethicone crosspolymer, methicone, propylparaben, silica, tocopheryl acetate, butylparaben, distearyldimonium chloride, glycosyl trehalose, hydrogenated starch hydrolysate, dimethicone, ci 77492, aloe barbadensis leaf juice, bisabolol, camellia sinensis leaf extract, hydrolyzed lupine protein, morus nigra leaf ext, panax ginseng root ext, squalane, portulaca oleracea extract, rosa canina fruit oil, rosa centifolia flower water, rosemary leaf ext, stearyl glycyrrhetinate
skin protectant
keep out of reach of the children
pump a small amount on the fingertips and apply evenly to the entire face before using a foundation or powder pact
- Stop using if sensitivities occurs and consult with dermatologist
- sensitivities such as red marks, intumescence, urtication, irritation during use
-Have sensitivities as above on applied part by direct sun ray
- Do not store at high and low temperatures and avoid sunlight.
for external use only
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 75847-1712-1 | 2024-06-28 | C162847 | 48780-1 | d6a99b39-9cd6-a426-e053-dadaa90af4c2 | Drug Facts |
| 75847-1712-1 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-9cd6-a426-e053-dadaa90af4c2 | Drug Facts |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ZINC OXIDE | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| ZINC OXIDE | ACTIVE MOIETY | SOI2LOH54Z | 1 | |
| ALUMINUM HYDROXIDE | INACTIVE INGREDIENT | 5QB0T2IUN0 | 1 | |
| CYCLOMETHICONE | INACTIVE INGREDIENT | NMQ347994Z | 1 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| SQUALENE | INACTIVE INGREDIENT | 7QWM220FJH | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 75847-1712 | 75847-1712-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DIMETHICONE | 92RU3N3Y1O | IACT |
| ALUMINUM HYDROXIDE | 5QB0T2IUN0 | IACT |
| CYCLOMETHICONE | NMQ347994Z | IACT |
| SQUALENE | 7QWM220FJH | IACT |
| ZINC OXIDE | SOI2LOH54Z | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALUMINUM HYDROXIDE | ALUMINUM HYDROXIDE | 5QB0T2IUN0 | CREAM / TOPICAL | 5 %w/w | ||
| ALUMINUM HYDROXIDE | ALUMINUM HYDROXIDE | 5QB0T2IUN0 | TABLET / ORAL | 50 mg | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | AEROSOL, FOAM / TOPICAL | 376 mg | ||
| ALUMINUM HYDROXIDE | ALUMINUM HYDROXIDE | 5QB0T2IUN0 | CAPSULE / ORAL | NA | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | LOTION / TOPICAL | 3510 mg | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | CREAM, AUGMENTED / TOPICAL | 389 mg | ||
| ALUMINUM HYDROXIDE | ALUMINUM HYDROXIDE | 5QB0T2IUN0 | OINTMENT / TOPICAL | NA | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | CREAM / TOPICAL | 358 mg | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | SOLUTION / TOPICAL | 11.57 %w/v |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 1bcec96e-54cd-8c44-e063-6294a90ace9e | 84f5060a-273c-483f-8c02-c72af449447d | 2024-06-26 | Warnings | 84f5060a-273c-483f-8c02-c72af449447d |
Adverse event summaries are temporarily unavailable. Other product information remains available.